Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chlorhexidine gluconate + hydrogen peroxide is an antiseptic combination used primarily in hospital settings for advanced oral hygiene and the prevention of healthcare-associated infections, such as ventilator-associated pneumonia (VAP). This combination therapy utilizes the distinct antimicrobial mechanisms of two agents: chlorhexidine gluconate, a bisbiguanide that provides long-lasting bacteriostatic and bactericidal effects by disrupting microbial cell membranes, and hydrogen peroxide, an oxidizing agent that debrides oral tissues and provides immediate antimicrobial action through the release of oxygen free radicals. These products are typically packaged in comprehensive oral care kits containing suction swabs and specialized solutions, designed to control dental plaque and treat gingivitis in patients who are unable to perform independent oral care, such as those in intensive care units.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorhexidine gluconate + hydrogen peroxide.